Orthofix Medical (OFIX) Total Non-Current Liabilities (2010 - 2026)
Orthofix Medical's (OFIX) quarterly Total Non-Current Liabilities came in at $395.3 million in Q1 2026, up 24.06% YoY from $318.6 million in Q1 2025, and up 14.6% on a QoQ basis from $344.9 million in Q4 2025.
Orthofix Medical (OFIX) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Orthofix Medical (OFIX) has 17 years of Total Non-Current Liabilities data on file, last reported at $395.3 million in Q1 2026.
- Quarterly Total Non-Current Liabilities rose 24.06% year-over-year to $395.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $395.3 million (up 24.06% YoY) and the FY2025 annual result came in at $344.9 million, down 7.96% from the prior year.
- Total Non-Current Liabilities advanced to $395.3 million in Q1 2026, from $344.9 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $395.3 million in Q1 2026 to a low of $97.1 million in Q3 2022.
- A 5-year average of $261.7 million and a median of $287.4 million in 2024 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities decreased 16.02% — and 2023, when it jumped 209.23%.
- Tracing OFIX's Total Non-Current Liabilities over 5 years: stood at $102.9 million in 2022, then jumped by 209.23% to $318.1 million in 2023, then gained by 17.82% to $374.8 million in 2024, then slipped by 7.96% to $344.9 million in 2025, then grew by 14.6% to $395.3 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $395.3 million (Q1 2026), $344.9 million (Q4 2025), and $334.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Orthofix Medical | 409.06 Mn | 304.66 Mn | 149.71 Mn | 391.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 391.50 Mn |
| Mar 31, 2026 | 395.31 Mn |
| Dec 31, 2025 | 344.93 Mn |
| Sep 30, 2025 | 334.31 Mn |
| Jun 30, 2025 | 368.81 Mn |
| Mar 31, 2025 | 318.64 Mn |
| Dec 31, 2024 | 374.77 Mn |
| Sep 30, 2024 | 292.14 Mn |
| Jun 30, 2024 | 287.44 Mn |
| Mar 31, 2024 | 284.04 Mn |
| Dec 31, 2023 | 318.09 Mn |
| Sep 30, 2023 | 241.25 Mn |
| Jun 30, 2023 | 254.50 Mn |
| Mar 31, 2023 | 201.64 Mn |
| Dec 31, 2022 | 102.86 Mn |
| Sep 30, 2022 | 97.06 Mn |
| Jun 30, 2022 | 118.72 Mn |
| Mar 31, 2022 | 114.72 Mn |
| Dec 31, 2021 | 122.49 Mn |
| Sep 30, 2021 | 100.05 Mn |